GAITHERSBURG, Md., May 24, 2016 /PRNewswire/ -- For more than 15 years, VSL#3® (www.VSL3.com) continues to rise to the top in the ever-growing category of probiotics as the high-potency probiotic medical food brand clinically proven in numerous studies to be beneficial for serious digestive disorders. Distributed in the U.S. by Sigma-Tau Pharmaceuticals under agreement with VSL Pharmaceuticals, VSL#3 is the most recommended probiotic medical food for the dietary management of ulcerative colitis (UC), irritable bowel syndrome (IBS) and ileal pouch.
VSL#3 has been used in more than 170 studies and is mentioned by several healthcare organizations and associations worldwide, including the Triennial Yale/Harvard Workshop for the past 10 years showing benefit for patients who suffer from ulcerative colitis.
"More healthcare professionals recommend the VSL#3 brand to their patients suffering with serious digestive issues than any other probiotic, a fact that's supported by VSL#3's success over the last fifteen years," says Mary Ocnean, Vice President, Commercial Operations, Consumer Products at Sigma-Tau Pharmaceuticals. "The success of the VSL#3 brand not only signifies strong confidence in the brand but is a prime example of our dedication to continuously support healthcare professionals by providing them with the quality and trusted brand they've been recommending to their patients with IBS, ulcerative colitis or ileal pouch so they can lead healthier and happier lives."
VSL#3's strong legacy and loyalty is based on recognized scientific principles and backed by a company that has been dedicated to manufacturing the most high quality brand that physicians can depend on for their patients with serious digestive disorders.
"Not only is the VSL#3 brand supported by more than 170 studies and reviews, many of which are published in peer-reviewed journals, but experience with the brand for patients with ulcerative colitis and ileal pouch has proven to be extremely effective," says Dr. Raymond, who recommends VSL#3 for its efficacy and strong track record. "Like myself, doctors prescribe the VSL#3 brand for some of the toughest digestive issues out there," adds Dr. Raymond. "That shows the trust and is the reason why healthcare professionals recommend the brand as one of the most potent probiotics on the market."
For 15 years, patients have trusted the VSL#3 brand as their probiotic medical food of choice. With a variety of strains of live bacteria that provide specific nutritional requirements which come from having a medical condition that cannot be met by simply modifying one's diet, VSL#3 has been clinically shown to be beneficial in the dietary management of IBS, ulcerative colitis or ileal pouch. In an effort to connect with its patients, VSL#3 has established an active Facebook community of digestive sufferers www.Facebook.com/VSL3probiotic. According to Ocnean, "Members get the opportunity to connect with others interested in high-potency probiotics, IBS or ulcerative colitis, and can get dietary and lifestyle tips from healthcare experts, receive special offers and promotions. It's also a great way for us to share with patients what is going on with the brand."
For more information about VSL#3, healthcare professionals can visit the "Healthcare Professional" section of the VSL#3 website where they will find additional information on the studies and support behind VSL#3 and inquire about product samples for their office.
Patients can visit www.vsl3.com, where they will find information about VSL#3, IBS-Friendly recipes, up to date product information and more.
About Sigma-Tau Pharmaceuticals, Inc.:
Sigma-Tau Pharmaceuticals, Inc. is a U.S.-based, wholly owned subsidiary of the sigma-tau Group, and is dedicated to the global development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland, and the company's marketed products are focused on cancer, kidney disease, gastrointestinal and genetic related disorders. The company also has clinical development programs focused on hematological cancer, malaria, and other areas of unmet medical need. For more information about Sigma-Tau Pharmaceuticals, Inc., visit www.sigmatau.com.
About VSL Pharma:
VSL Pharmaceuticals, Inc. provides medical food for the dietary management of patients in the United States and internationally. It offers VSL#3, a probiotic medical food for the dietary management of patients with ulcerative colitis, irritable bowel syndrome, and ileal pouch. It offers its products through pharmacies and wholesalers, as well as online. VSL Pharmaceuticals, Inc. was incorporated in 2000 and is based in Gaithersburg, Maryland.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/15-years-and-going-strong-vsl3-maintains-leadership-in-the-probiotic-medical-food-category-300273373.html
SOURCE Sigma-Tau Pharmaceuticals, Inc.